- Home
- AVIR vs JILL Comparison
AVIR vs JILL Comparison
Compare AVIR & JILL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AVIR | JILL |
|---|---|---|
| Founded | 2012 | 1959 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 266.4M | 233.1M |
| IPO Year | 2020 | 2017 |
Fundamental Metrics
Financial Performance| Metric | AVIR | JILL |
|---|---|---|
| Price | $3.37 | $14.15 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 4 |
| Target Price | $6.00 | ★ $18.50 |
| AVG Volume (30 Days) | ★ 393.0K | 138.5K |
| Earning Date | 11-12-2025 | 12-10-2025 |
| Dividend Yield | N/A | ★ 2.21% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.19 |
| Revenue | N/A | ★ $600,981,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.76 |
| P/E Ratio | ★ N/A | $6.60 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.46 | $13.32 |
| 52 Week High | $4.02 | $28.94 |
Technical Indicators
Market Signals| Indicator | AVIR | JILL |
|---|---|---|
| Relative Strength Index (RSI) | 53.27 | 46.43 |
| Support Level | $3.29 | $13.68 |
| Resistance Level | $3.63 | $14.49 |
| Average True Range (ATR) | 0.13 | 0.57 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 45.53 | 33.93 |
Price Performance
Historical ComparisonAbout AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About JILL J. Jill Inc.
J.Jill Inc is a national lifestyle brand that provides apparel, footwear, and accessories. The company's products are marketed under the J.Jill brand name and sold through its two channels: its e-commerce platform and catalog (Direct) and its retail stores (Retail). Revenue is derived from the sale of apparel and accessory merchandise through the company's Retail and Direct channels, which include website and catalog phone orders. Revenue also includes shipping and handling fees collected from customers.